The FDA Amendments Act: Insight & Industry Implications
28 December 2007
In the fall of 2007, four important programmes at the US Food & Drug Administration were due to expire: •The Prescription Drug User Fee Act, via which drug makers pay substantial fees to have their applications assessed by the FDA, fees that go to hire more staffers than would be possible with Congressional...
View attached document
Please Login to read the full article.
28 December 2007
View attached document
Please Login to read the full article.
RELATED CONTENT
NEWS
- US Capitol Capsule: House passes health funding cuts as US faces government shutdown
- US Capitol Capsule: Lawmakers give 'Super Congress' two cents' worth on big bucks cuts
- US Capitol Capsule: House adopts patent reform, but fee change could be trouble for Senate
- US Capitol Capsule: Obama pushes for crowdfunding, while SEC panel cautious
COMMENT
Other Informa Comment
EVENTS
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
26 March 2012
Copenhagen, Denmark
JOB OF THE WEEK
Promote your vacancy here
